PAtHways to Improved Care in PAH
Both the diagnosis and treatment of pulmonary arterial hypertension (PAH) can be complex. Diagnosis may be complicated by its nonspecific symptoms and complex differential diagnosis, whereas treatment selection may be challenging due to the number of therapies, combinations of different therapies, and recent updates to treatment guidelines and algorithms. Immerse yourself in this PAH curriculum that features vlogs, a clinical commentary, and a Q&A end-of-year touchpoint activity on Hot Topics in PAH with expert faculty from Cedars-Sinai Medical Center, the Texas Tech University Health Sciences Center El Paso, the University of Michigan, and the University of Utah. Upon completion of these activities, clinicians will be better able to apply appropriate screening and diagnostic methods, treatment algorithms, and risk assessment tools to enhance their recognition and management of PAH.
Featured topic areas include:
• Screening and diagnosis
• Risk assessment and stratification
• Treatment selection according to risk assessment
• Considerations for oral combination therapy
• Emerging therapies for PAH
• Management of PAH patients during COVID-19
From Risk Assessment to Treatment: Real-World Approaches to PAH
Clinical Commentary
In this clinical commentary, join cardiology expert Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan and pulmonology expert Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center as they provide real-world advice on the management of pulmonary arterial hypertension (PAH). These experts will discuss their best practices for:
• Risk assessment and stratification
• Use of oral combination therapies
• Management of PAH patients during COVID-19
Faculty: Victor Tapson, MD and Vallerie McLaughlin, MD
Release Date:
Expiration Date: November 30, 2022
CME/CE is no longer available for this activity
A Closer Look at PAH Diagnosis, Screening, and Risk Assessment
Clinical CommentaryIn this short “How I Do It” vlog, expert faculty Dr. John Ryan, Director, Pulmonary Hypertension Comprehensive Care Center, University of Utah Hospital showcases personal experiences incorporating updated recommendations in clinical practice as well as diagnostic approaches, screening methods, and the importance of risk assessment. Upon completion of this activity, clinicians will be better able to incorporate effective screening techniques and appropriate diagnostic and risk assessment tools within clinical practice to improve outcomes for patients with PAH.
Faculty: John Ryan MD, MB, BCH, BAO
Release Date:
Expiration Date: November 30, 2022
CME/CE is no longer available for this activity
Oral Combination Therapy: The PAtH to Improved Patient Care in PAH
Clinical Commentary
Are you interested in finding out how you can more effectively manage your patients with PAH? In this short “How I Do It” vlog, expert faculty Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan discusses recommendations for the use of oral combination therapies in PAH. Stay on the right PAtH with therapeutic options available for your patients with PAH and hear more on:
• Treatment selection according to risk assessment
• Considerations for oral combination therapy
• Experiences with oral combination therapy
• Emerging therapies for PAH
Faculty: Vallerie McLaughlin, MD
Release Date:
Expiration Date: November 30, 2022
CME/CE is no longer available for this activity
Hot Topics in PAH: What We’ve Learned in the Past Year
CME TouchpointHow can clinicians improve early detection of PAH? What are some practical strategies for managing PAH patients in today’s world? What recent data support current treatment strategies, and what are emerging therapeutic options? This 30-minute multimedia Q&A touchpoint “Hot Topics” CME activity features leading pulmonology expert Dan Schuller, MD, from Texas Tech University Health Sciences Center who discusses the latest data and recommendations, along with his insights for applying this information in clinical practice. This activity features engaging images, charts, and short video snippets. Dive into recommendations from the 6th World Symposium on Pulmonary Hypertension, new risk assessment tools, and more!
Faculty: Dan Schuller, MD
Release Date:
Expiration Date: November 29, 2022
CME/CE is no longer available for this activity
